ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
131.065,44
-1,55%
S&P 500
5.702,55
-0,19%
US Dollar vs BRL
5,5146
1,64%
Bitcoin
63.200,78
0,40%
Brent Oil
74,135
-0,25%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Sophia Genetics SA (SOPH)

  7. Sophia Genetics SA (SOPH) Notícias

SOPH

Sophia Genetics (SOPH)

Sophia Genetics SA
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SOPH
DataHoraFonteTítuloCódigoCompanhia
19/09/202422:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SOPHSophia Genetics SA
14/09/202410:00PR Newswire (US)SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024NASDAQ:SOPHSophia Genetics SA
12/09/202408:00PR Newswire (US)SOPHiA GENETICS Announces Poster Presentations at ESMO 2024NASDAQ:SOPHSophia Genetics SA
12/09/202405:00PR Newswire (US)SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024NASDAQ:SOPHSophia Genetics SA
10/09/202411:28PR Newswire (US)SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy TestingNASDAQ:SOPHSophia Genetics SA
05/09/202409:30PR Newswire (US)SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024NASDAQ:SOPHSophia Genetics SA
04/09/202407:00PR Newswire (US)SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024NASDAQ:SOPHSophia Genetics SA
28/08/202414:30PR Newswire (US)SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth ConferenceNASDAQ:SOPHSophia Genetics SA
14/08/202404:00PR Newswire (US)SOPHiA DDM™ Platform Certified Under IVDRNASDAQ:SOPHSophia Genetics SA
06/08/202408:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SOPHSophia Genetics SA
06/08/202407:45PR Newswire (US)SOPHiA GENETICS Reports Second Quarter 2024 ResultsNASDAQ:SOPHSophia Genetics SA
29/07/202411:30PR Newswire (US)SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™NASDAQ:SOPHSophia Genetics SA
25/07/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SOPHSophia Genetics SA
24/07/202412:59PR Newswire (US)SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelixNASDAQ:SOPHSophia Genetics SA
24/07/202411:00PR Newswire (US)SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelixNASDAQ:SOPHSophia Genetics SA
23/07/202407:45PR Newswire (US)SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024NASDAQ:SOPHSophia Genetics SA
22/07/202409:57Edgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:SOPHSophia Genetics SA
04/07/202403:30PR Newswire (US)India-Based Dhiti Omics is Now Live on SOPHiA DDM™NASDAQ:SOPHSophia Genetics SA
24/06/202410:47GlobeNewswire Inc.SOPHiA GENETICS Publishes Results of 2024 Annual General MeetingNASDAQ:SOPHSophia Genetics SA
24/06/202403:00PR Newswire (US)SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) ApplicationNASDAQ:SOPHSophia Genetics SA
13/06/202407:00PR Newswire (US)SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ PlatformNASDAQ:SOPHSophia Genetics SA
07/06/202417:55Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:SOPHSophia Genetics SA
30/05/202413:39PR Newswire (US)SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient CareNASDAQ:SOPHSophia Genetics SA
29/05/202411:00PR Newswire (US)SOPHiA GENETICS to Launch New Whole Genome Sequencing CapabilitiesNASDAQ:SOPHSophia Genetics SA
20/05/202411:02PR Newswire (US)SOPHiA GENETICS Announces Instituto Mário Penna as New CustomerNASDAQ:SOPHSophia Genetics SA
16/05/202407:02PR Newswire (US)Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICSNASDAQ:SOPHSophia Genetics SA
07/05/202407:45GlobeNewswire Inc.SOPHiA GENETICS Reports First Quarter 2024 ResultsNASDAQ:SOPHSophia Genetics SA
30/04/202408:05GlobeNewswire Inc.SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
23/04/202411:29GlobeNewswire Inc.SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024NASDAQ:SOPHSophia Genetics SA
23/04/202406:05PR Newswire (US)SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in AfricaNASDAQ:SOPHSophia Genetics SA
 Apresentando as notícias mais relevantes sobre:NASDAQ:SOPH

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
HAGA3
HAGA ON
BOV
JFEN3
JOAO FORTES ON
BOV
AZEV4
AZEVEDO PN
BOV
COGN3
COGNA ON
BOV
AGXY3
Agrogalaxy Participacoes ON
BOV
PRIO3
PETRORIO ON
BOV
OIBR3
OI ON
BOV
GFSA3
GAFISA ON
BOV
AZEV3
AZEVEDO ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
RCSL4
RECRUSUL PN
BOV
VVEO3
CM Hospitalar ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
TELB4
TELEBRAS PN
BOV
CVCB3
CVC BRASIL ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados